Followers | 840 |
Posts | 121709 |
Boards Moderated | 10 |
Alias Born | 09/05/2002 |

Thursday, February 09, 2023 7:42:30 PM
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent ABBV News
- AbbVie Declares Quarterly Dividend • PR Newswire (US) • 06/20/2025 12:00:00 PM
- AbbVie Announces New Data Demonstrating Atogepant (QULIPTA® / AQUIPTA®) Achieves Superiority Across All Endpoints in Phase 3 Head-to-Head Study Compared to Topiramate for Migraine Prevention • PR Newswire (US) • 06/18/2025 11:15:00 AM
- AbbVie Provides Update on VERONA Trial for Newly Diagnosed Higher-Risk Myelodysplastic Syndromes • PR Newswire (US) • 06/16/2025 01:00:00 PM
- Form 11-K - Annual report of employee stock purchase, savings and similar plans • Edgar (US Regulatory) • 06/13/2025 08:15:15 PM
- U.S. FDA Approves Expanded Indication for AbbVie's MAVYRET® (Glecaprevir/Pibrentasvir) as First and Only Treatment for People with Acute Hepatitis C Virus • PR Newswire (US) • 06/11/2025 04:31:00 PM
- AbbVie Invites People Living with Migraine to Enter the Second Annual AbbVie Migraine Career Catalyst Award™ Contest to Support Their Professional Goals • PR Newswire (US) • 06/03/2025 12:15:00 PM
- AbbVie to Present at the Goldman Sachs 46th Annual Global Healthcare Conference • PR Newswire (US) • 06/03/2025 12:00:00 PM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/30/2025 08:05:32 PM
- AbbVie Partners with Chicago Cubs on "Striking Out Cancer" • PR Newswire (US) • 05/30/2025 12:00:00 PM
- Class Action Filed Against Cerevel Therapeutics Holdings, Inc. (ABBV) Seeking Recovery for Investors - Contact The Gross Law Firm • PR Newswire (US) • 05/29/2025 09:45:00 AM
- AbbVie Features New Data Across Difficult-to-Treat Solid Tumors and Blood Cancers at ASCO 2025, Highlighting Breadth and Depth of its Oncology Portfolio • PR Newswire (US) • 05/27/2025 01:00:00 PM
- AbbVie and U of T Mississauga's SpinUp Announce Neuropeutics Inc as First AbbVie Biotech Innovators Award Recipient • PR Newswire (Canada) • 05/22/2025 03:00:00 PM
- AbbVie et SpinUp de l'Université de Toronto à Mississauga annoncent le premier lauréat du Prix AbbVie des innovateurs en biotechnologies : Neuropeutics Inc. • PR Newswire (Canada) • 05/22/2025 03:00:00 PM
- Cerevel Therapeutics Holdings, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before June 3, 2025 to Discuss Your Rights - ABBV • PR Newswire (US) • 05/22/2025 09:45:00 AM
- Shareholders that lost money on Cerevel Therapeutics Holdings, Inc.(ABBV) should contact The Gross Law Firm about pending Class Action - ABBV • PR Newswire (US) • 05/19/2025 05:04:00 PM
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Cerevel Therapeutics Holdings, Inc. Lawsuit - ABBV • PR Newswire (US) • 05/15/2025 09:45:00 AM
- U.S. FDA Approves EMRELIS™ (telisotuzumab vedotin-tllv) for Adults With Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC) With High c-Met Protein Overexpression • PR Newswire (US) • 05/14/2025 05:09:00 PM
- AbbVie and ADARx Pharmaceuticals Announce Collaboration and License Option Agreement to Develop Next-Generation siRNA Therapies Across Multiple Therapeutic Areas • PR Newswire (US) • 05/14/2025 12:55:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2025 09:05:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2025 09:05:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2025 09:05:11 PM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Cerevel Therapeutics Holdings, Inc.(ABBV) Shareholders • PR Newswire (US) • 05/12/2025 09:45:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2025 05:24:59 PM
- Class Action Filed Against Cerevel Therapeutics Holdings, Inc. (ABBV) - June 3, 2025 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 05/08/2025 09:45:00 AM
- AbbVie to Present at the Bank of America Securities Healthcare Conference • PR Newswire (US) • 05/06/2025 12:00:00 PM
FEATURED MedWellAi, Inc (formerly Integrated Ventures) Completes Corporate Rebranding And Transformation Into Ai-Driven Healthcare and Wellness • Jun 24, 2025 8:45 AM
FEATURED Envirotech (EVTV) Announces Vision for Multi-modal Electric Mobility Ecosystem • Jun 24, 2025 8:42 AM
Avant Technologies Creating New Company for Expansion of Diabetes Program • AVAI • Jun 24, 2025 8:00 AM
From Exploration to Execution: New Gold Player Emerges in One of Canada's Premier Mining Districts • ABX • Jun 23, 2025 8:45 AM
Authentic Holdings Inc. Partnership with Swerve TV Debuts with Highly Successful 'Ring of Combat' Live Broadcast • AHRO • Jun 18, 2025 12:45 PM
ePIC Blockchain Signs LOI with A.R.T. Digital to Redefine Bitcoin Miner Design with Breakthrough Air-Cooling Technology • CGAC • Jun 18, 2025 12:41 PM